Heartbeam Inc (BEAT)vsTempus AI, Inc. Class A Common Stock (TEM)
BEAT
Heartbeam Inc
$1.12
-2.61%
HEALTHCARE · Cap: $47.25M
TEM
Tempus AI, Inc. Class A Common Stock
$46.76
-4.24%
HEALTHCARE · Cap: $8.73B
Smart Verdict
WallStSmart Research — data-driven comparison
BEAT leads profitability with a 0.0% profit margin vs -19.3%. TEM earns a higher WallStSmart Score of 31/100 (F).
BEAT
Avoid16
out of 100
Grade: F
TEM
Avoid31
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Revenue surging 83.0% year-over-year
Areas to Watch
Trading at 16.0x book value
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
Trading at 16.9x book value
0.0% earnings growth
ROE of -89.5% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : BEAT
BEAT has a balanced fundamental profile.
Bull Case : TEM
The strongest argument for TEM centers on Revenue Growth. Revenue growth of 83.0% demonstrates continued momentum.
Bear Case : BEAT
The primary concerns for BEAT are Price/Book, Revenue Growth, EPS Growth.
Bear Case : TEM
The primary concerns for TEM are Price/Book, EPS Growth, Return on Equity. Debt-to-equity of 2.63 is elevated, increasing financial risk.
Key Dynamics to Monitor
BEAT profiles as a value stock while TEM is a hypergrowth play — different risk/reward profiles.
TEM is growing revenue faster at 83.0% — sustainability is the question.
BEAT generates stronger free cash flow (-3M), providing more financial flexibility.
Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
TEM scores higher overall (31/100 vs 16/100) and 83.0% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Heartbeam Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
BioTelemetry, Inc., a remote medical technology company, provides remote heart monitoring, remote blood glucose monitoring, centralized central laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research clients throughout the world. The company is headquartered in Malvern, Pennsylvania.
Visit Website →Tempus AI, Inc. Class A Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Tempus AI, Inc is a healthcare technology company. The company is headquartered in Chicago, Illinois.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?